Inflammation-related gene variants as risk factors for pancreatic cancer

Kaye M. Reid-Lombardo, Brooke L. Fridley, William R. Bamlet, Julie M Cunningham, Michael G. Sarr, Gloria M Petersen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Recent reports support an association between chronic inflammation and progression to pancreatic cancer (PC). Methods: This case-control, candidate gene association study evaluated 1,354 Caucasian patients with pancreatic ductal adenocarcinoma and 1,189 healthy Caucasian controls. We genotyped 1,538 single nucleotide polymorphism (SNP) in 102 genes from inflammatory pathways involving NF-κB. Primary tests of association assumed a multiplicative (log-additive) genotype effect; secondary analyses examined dominant, additive, and recessive SNP effects. Results: After adjusting for known risk factors for PC, single SNP analysis revealed an association between four SNPs in NOS1 and one in the CD101 gene with PC risk. These results, however, were not replicated in a PC case-control and cohort population. Conclusion: NOS1 and CD101 may be associated with a risk of PC; however, these findings did not replicate in other PC populations. Future research is needed into the possible role of NOS1 and CD101 for PC. Impact: This research shows a lack of association between genetic variation in 102 inflammation-related genes and PC. Future research is needed into the possible role of other inflammation-related genes and PC risk.

Original languageEnglish (US)
Pages (from-to)1251-1254
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume20
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Pancreatic Neoplasms
Inflammation
Genes
Single Nucleotide Polymorphism
Genetic Association Studies
Population
Adenocarcinoma
Genotype
Research

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Inflammation-related gene variants as risk factors for pancreatic cancer. / Reid-Lombardo, Kaye M.; Fridley, Brooke L.; Bamlet, William R.; Cunningham, Julie M; Sarr, Michael G.; Petersen, Gloria M.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 20, No. 6, 06.2011, p. 1251-1254.

Research output: Contribution to journalArticle

Reid-Lombardo, Kaye M. ; Fridley, Brooke L. ; Bamlet, William R. ; Cunningham, Julie M ; Sarr, Michael G. ; Petersen, Gloria M. / Inflammation-related gene variants as risk factors for pancreatic cancer. In: Cancer Epidemiology Biomarkers and Prevention. 2011 ; Vol. 20, No. 6. pp. 1251-1254.
@article{ff3448e216a34df3a2477671063c07e4,
title = "Inflammation-related gene variants as risk factors for pancreatic cancer",
abstract = "Background: Recent reports support an association between chronic inflammation and progression to pancreatic cancer (PC). Methods: This case-control, candidate gene association study evaluated 1,354 Caucasian patients with pancreatic ductal adenocarcinoma and 1,189 healthy Caucasian controls. We genotyped 1,538 single nucleotide polymorphism (SNP) in 102 genes from inflammatory pathways involving NF-κB. Primary tests of association assumed a multiplicative (log-additive) genotype effect; secondary analyses examined dominant, additive, and recessive SNP effects. Results: After adjusting for known risk factors for PC, single SNP analysis revealed an association between four SNPs in NOS1 and one in the CD101 gene with PC risk. These results, however, were not replicated in a PC case-control and cohort population. Conclusion: NOS1 and CD101 may be associated with a risk of PC; however, these findings did not replicate in other PC populations. Future research is needed into the possible role of NOS1 and CD101 for PC. Impact: This research shows a lack of association between genetic variation in 102 inflammation-related genes and PC. Future research is needed into the possible role of other inflammation-related genes and PC risk.",
author = "Reid-Lombardo, {Kaye M.} and Fridley, {Brooke L.} and Bamlet, {William R.} and Cunningham, {Julie M} and Sarr, {Michael G.} and Petersen, {Gloria M}",
year = "2011",
month = "6",
doi = "10.1158/1055-9965.EPI-11-0264",
language = "English (US)",
volume = "20",
pages = "1251--1254",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - Inflammation-related gene variants as risk factors for pancreatic cancer

AU - Reid-Lombardo, Kaye M.

AU - Fridley, Brooke L.

AU - Bamlet, William R.

AU - Cunningham, Julie M

AU - Sarr, Michael G.

AU - Petersen, Gloria M

PY - 2011/6

Y1 - 2011/6

N2 - Background: Recent reports support an association between chronic inflammation and progression to pancreatic cancer (PC). Methods: This case-control, candidate gene association study evaluated 1,354 Caucasian patients with pancreatic ductal adenocarcinoma and 1,189 healthy Caucasian controls. We genotyped 1,538 single nucleotide polymorphism (SNP) in 102 genes from inflammatory pathways involving NF-κB. Primary tests of association assumed a multiplicative (log-additive) genotype effect; secondary analyses examined dominant, additive, and recessive SNP effects. Results: After adjusting for known risk factors for PC, single SNP analysis revealed an association between four SNPs in NOS1 and one in the CD101 gene with PC risk. These results, however, were not replicated in a PC case-control and cohort population. Conclusion: NOS1 and CD101 may be associated with a risk of PC; however, these findings did not replicate in other PC populations. Future research is needed into the possible role of NOS1 and CD101 for PC. Impact: This research shows a lack of association between genetic variation in 102 inflammation-related genes and PC. Future research is needed into the possible role of other inflammation-related genes and PC risk.

AB - Background: Recent reports support an association between chronic inflammation and progression to pancreatic cancer (PC). Methods: This case-control, candidate gene association study evaluated 1,354 Caucasian patients with pancreatic ductal adenocarcinoma and 1,189 healthy Caucasian controls. We genotyped 1,538 single nucleotide polymorphism (SNP) in 102 genes from inflammatory pathways involving NF-κB. Primary tests of association assumed a multiplicative (log-additive) genotype effect; secondary analyses examined dominant, additive, and recessive SNP effects. Results: After adjusting for known risk factors for PC, single SNP analysis revealed an association between four SNPs in NOS1 and one in the CD101 gene with PC risk. These results, however, were not replicated in a PC case-control and cohort population. Conclusion: NOS1 and CD101 may be associated with a risk of PC; however, these findings did not replicate in other PC populations. Future research is needed into the possible role of NOS1 and CD101 for PC. Impact: This research shows a lack of association between genetic variation in 102 inflammation-related genes and PC. Future research is needed into the possible role of other inflammation-related genes and PC risk.

UR - http://www.scopus.com/inward/record.url?scp=79958049770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958049770&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-11-0264

DO - 10.1158/1055-9965.EPI-11-0264

M3 - Article

VL - 20

SP - 1251

EP - 1254

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 6

ER -